Skip to main content
IBN
NYSE Finance

ICICI Bank Q1 profit climbs 16% to Rs. 14,805 crore; board names new director and lifts overseas borrowing cap

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Bank Stocks · Financial
Sentiment info
Positive
Importance info
7
Price
$29.45
Mkt Cap
$108.902B
52W Low
$25.082
52W High
$34.545
52W Position info
17% above low
Off High info
15% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

IBN sits 17% above its 52-week low of $25.082.

Summary

ICICI Bank posted Q1 FY2027 net profit of Rs. 14,805 crore, up 15.9% YoY, alongside robust loan and fee growth and improving asset quality. The board also appointed a new independent director and increased the overseas borrowing limit to $2.5 billion.


Key Events · Earnings and Guidance · IBN

  • Q1 Profit Up 15.9% YoY

    Standalone net profit rose to Rs. 14,805 crore ($1.6 billion) from Rs. 12,768 crore a year ago, driven by 12.7% NII growth and 23.5% fee income increase.

  • Asset Quality Improves

    Gross NPA ratio declined to 1.38% from 1.67% YoY; net NPA ratio at 0.35%. Provisioning coverage ratio on NPAs stood at 74.7%.

  • New Independent Director Appointed

    Board approved appointment of Mrugank Paranjape, former MD & CEO of MCX, as Additional (Independent) Director for a five-year term starting August 1, 2026, subject to shareholder approval.

  • Overseas Borrowing Limit Raised to $2.5B

    Board approved a revised limit of up to USD 2.50 billion for overseas bond/note/CD issuances, up from the previous limit (undisclosed), enhancing funding flexibility.


Analysis · IBN · Finance

A robust start to FY2027 saw net profit advance 15.9% year-on-year to Rs. 14,805 crore, fueled by a 12.7% rise in NII and a 23.5% jump in fee income. Asset quality continued to strengthen—the gross NPA ratio narrowed to 1.38% from 1.67% a year earlier. In separate actions, the board brought on capital markets veteran Mrugank Paranjape as an independent director and raised the overseas bond issuance ceiling to $2.5 billion, underscoring confidence in funding flexibility. Together, the results highlight the bank's sustained growth and operational resilience.

How filings like this one have moved

In the 30 days to Sep 13, 2026, 29.5% of the 1672 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.22%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, IBN was trading at $29.45 on NYSE in the Finance sector, with a market capitalization of approximately $108.9B. The 52-week trading range was $25.08 to $34.55. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IBN - Latest Insights

IBN
Sep 10, 2026, 6:09 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $29.02
Real-time Price: $29.39 info
Change: +$0.370 (+1%) info
Market Cap: $103.406B info
IBN
Sep 08, 2026, 6:05 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $29.75
Real-time Price: $29.39 info
Change: -$0.360 (-1%) info
Market Cap: $103.406B info
IBN
Sep 03, 2026, 6:05 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $30.65
Real-time Price: $29.39 info
Change: -$1.26 (-4%) info
Market Cap: $103.406B info
IBN
Jul 22, 2026, 4:09 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $29.45
Real-time Price: $29.39 info
Change: -$0.060 (-0.20%) info
Market Cap: $103.406B info
IBN
Jul 20, 2026, 6:30 AM EDT
Filing Type: 20-F
Importance Score:
7
Price at Filing: $29.80
Real-time Price: $29.39 info
Change: -$0.410 (-1%) info
Market Cap: $103.406B info